When should RhD-negative recipients be spared the transfusion of DEL red cells to avoid anti-D alloimmunization?

Transfusion. 2022 Nov;62(11):2405-2408. doi: 10.1111/trf.17122. Epub 2022 Sep 26.

Authors

Hitoshi Ohto¹, Willy Albert Flegel², Hana Safic Stanic³

Affiliations

¹ Departments of Mesenchymal Stem Cell Research, Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
² Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
³ Department of Immunohematology, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.

No abstract available

Keywords: DEL; alloimmunization; anti-D; molecular typing; red cell genotyping.

Publication types

Research Support, N.I.H., Intramural

MeSH terms

Blood Transfusion
Humans
Isoantibodies
Rh-Hr Blood-Group System*
Rho(D) Immune Globulin*

Substances

RHO(D) antibody
Rho(D) Immune Globulin
Rh-Hr Blood-Group System
Isoantibodies

Grants and funding